Kazia Therapeutics (Kazia Therapeutics) Total Assets : $18.85 Mil (As of Jun. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Kazia Therapeutics Total Assets?

Kazia Therapeutics's Total Assets for the quarter that ended in Jun. 2023 was $18.85 Mil.

During the past 12 months, Kazia Therapeutics's average Total Assets Growth Rate was -23.50% per year. During the past 3 years, the average Total Assets Growth Rate was 15.80% per year. During the past 5 years, the average Total Assets Growth Rate was 6.60% per year. During the past 10 years, the average Total Assets Growth Rate was 30.60% per year.

During the past 13 years, Kazia Therapeutics's highest 3-Year average Total Assets Growth Rate was 130.20%. The lowest was -57.00%. And the median was -9.45%.

Total Assets is connected with ROA %. Kazia Therapeutics's annualized ROA % for the quarter that ended in Jun. 2023 was -49.08%. Total Assets is also linked to Revenue through Asset Turnover. Kazia Therapeutics's Asset Turnover for the quarter that ended in Jun. 2023 was 0.00.

Kazia Therapeutics Total Assets Historical Data

The historical data trend for Kazia Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kazia Therapeutics Total Assets Chart

Kazia Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

14.71

15.92

43.65

25.22

18.85

Kazia Therapeutics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Assets	Get a 7-Day Free Trial															43.65	31.95	25.22	18.78	18.85

Kazia Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Kazia Therapeutics's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	8.087	+	10.761
	=	18.85

Kazia Therapeutics's Total Assets for the quarter that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2023 )	+	Total Liabilities (Q: Jun. 2023 )
	=	8.087	+	10.761
	=	18.85

Kazia Therapeutics (NAS:KZIA) Total Assets Explanation

Total Assets is connected with ROA %.

Kazia Therapeutics's annualized ROA % for the quarter that ended in Jun. 2023 is

ROA %	=	Net Income (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	-9.234	/	( (18.783	+	18.848)	/ 2 )
	=	-9.234	/	18.8155
	=	-49.08 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Kazia Therapeutics's Asset Turnover for the quarter that ended in Jun. 2023 is

	Asset Turnover
=	Revenue (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
=	0	/	( (18.783	+	18.848)	/ 2 )
=	0	/	18.8155
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Kazia Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Kazia Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Kazia Therapeutics (Kazia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kazia Therapeutics Ltd (NAS:KZIA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000

Website

https://www.kaziatherapeutics.com

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Executives

Josiah T Austin	director, 10 percent owner	4673 CHRISTOPHER PLACE, DALLAS TX 75204
El Coronado Holdings, Llc	10 percent owner	4673 CHRISTOPHER PLACE, DALLAS TX 75204